FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W18307508> ?p ?o ?g. }

• W18307508 abstract "Head and neck squamous cell carcinoma (HNSCC) is characterized by the overexpression of the epidermal growth factor receptor. However, molecular targeting strategies against EGFR have not improved the 5-year survival rates of HNSCC patients. EGFR tyrosine kinase inhibitors displayed limited clinical responses in Phase II trials and the FDA-approved monoclonal antibody cetuximab (C225) did not prevent the occurrence of secondary tumors and distant metastases. G-protein-coupled receptor ligands; gastrin-releasing peptide (GRP), prostaglandin E2 (PGE2) and bradykinin (BK) have all been reported to activate EGFR in HNSCC via extracellular release of EGFR ligands TGF-a and AR. To improve the efficacy of EGFR inhibition in HNSCC, we investigated the efficacy of targeting common signaling intermediates involved in GPCR-EGFR crosstalk. We previously reported that GRP mediated release of EGFR ligands via phosphoinositide-dependent kinase 1 (PDK1) - dependent phosphorylation of a disintegrin and metalloprotease 17 (ADAM17). We subsequently investigated whether PDK1 mediates EGFR activation downstream of PGE2, BK and LPA pathways and the efficacy of different PDK1 targeting strategies in HNSCC. PGE2, BK and LPA-mediated EGFR phosphorylation was abrogated in PDK1 siRNA-transfected HNSCC cells. PDK1 siRNA also decreased PGE2 and BK-mediated HNSCC growth in vitro. Expression of kinase-dead PDK1 (PDK1M) decreased PGE2 -mediated HNSCC growth. PDK1M HNSCC cells demonstrated reduced proliferation compared to control HNSCC cells. HNSCC cells displayed nanomolar sensitivity to the PDK1 inhibitor OSU-03012 compared to normal mucosal cells. Combined treatment with the EGFR TKIs erlotinib or AG1478, plus OSU-03012 enhanced anti-proliferative effects. We have reported that PGE2 and BK mediated MAPK phosphorylation in the presence of EGFR inhibition, and combined GPCR and EGFR demonstrated additive to synergistic anti-tumor effects. To elucidate the EGFR-independent signaling mediated by GPCRs, we used a forward phase phosphoprotein array to identify potential molecular targets that can potentiate EGFR inhibition. We observed that p70S6K phosphorylation was induced in EGFR siRNA-transfected cells and sustained in cetuximab (C225)-treated cells following PGE2 or BK stimulation. Further investigation showed that p70S6K phosphorylation mediated by EGFR downmodulation was dependent on PDK1 and PKCa expression. Combined targeting of EGFR with cetuximab and p70S6K with the mTOR inhibitor RAD001 decreased GPCR-mediated growth in vitro and in vivo. The results from this study have indicated that targeting the GPCR signaling intermediates PDK1 and p70S6K in conjunction with EGFR may be beneficial therapeutic strategies for the subset of HNSCC patients that respond poorly to cetuximab treatment." @default.
• W18307508 created "2016-06-24" @default.
• W18307508 creator A5008062526 @default.
• W18307508 date "2009-08-05" @default.
• W18307508 modified "2023-09-23" @default.
• W18307508 title "Investigation of the mechanisms and therapeutic implications of crosstalk between G-protein-coupled receptors and the epidermal growth factor receptor in HNSCC" @default.
• W18307508 cites W110079119 @default.
• W18307508 cites W1490790087 @default.
• W18307508 cites W1492624446 @default.
• W18307508 cites W1532527807 @default.
• W18307508 cites W1536336415 @default.
• W18307508 cites W1543291357 @default.
• W18307508 cites W1581824974 @default.
• W18307508 cites W1603274157 @default.
• W18307508 cites W1668194762 @default.
• W18307508 cites W1766452247 @default.
• W18307508 cites W1893360284 @default.
• W18307508 cites W1964321121 @default.
• W18307508 cites W1966803171 @default.
• W18307508 cites W1966867506 @default.
• W18307508 cites W1967096085 @default.
• W18307508 cites W1970136142 @default.
• W18307508 cites W1970550717 @default.
• W18307508 cites W1971119203 @default.
• W18307508 cites W1971836864 @default.
• W18307508 cites W1972113997 @default.
• W18307508 cites W1972590376 @default.
• W18307508 cites W1972821731 @default.
• W18307508 cites W1974024530 @default.
• W18307508 cites W1977733200 @default.
• W18307508 cites W1978504284 @default.
• W18307508 cites W1978800133 @default.
• W18307508 cites W1979224825 @default.
• W18307508 cites W1981493299 @default.
• W18307508 cites W1982952843 @default.
• W18307508 cites W1983154518 @default.
• W18307508 cites W1983393354 @default.
• W18307508 cites W1983698019 @default.
• W18307508 cites W1984034244 @default.
• W18307508 cites W1987578146 @default.
• W18307508 cites W1994727614 @default.
• W18307508 cites W1995577203 @default.
• W18307508 cites W1996092483 @default.
• W18307508 cites W1997298413 @default.
• W18307508 cites W1998311633 @default.
• W18307508 cites W1998394615 @default.
• W18307508 cites W2000308166 @default.
• W18307508 cites W2001480136 @default.
• W18307508 cites W2001786879 @default.
• W18307508 cites W2002611375 @default.
• W18307508 cites W2002885378 @default.
• W18307508 cites W2005204942 @default.
• W18307508 cites W2005227821 @default.
• W18307508 cites W2005631145 @default.
• W18307508 cites W2008395005 @default.
• W18307508 cites W2010421388 @default.
• W18307508 cites W2010703150 @default.
• W18307508 cites W2011793282 @default.
• W18307508 cites W2012289375 @default.
• W18307508 cites W2012315119 @default.
• W18307508 cites W2013699970 @default.
• W18307508 cites W2015190128 @default.
• W18307508 cites W2015946454 @default.
• W18307508 cites W2016764257 @default.
• W18307508 cites W2017249285 @default.
• W18307508 cites W2022056371 @default.
• W18307508 cites W2025974334 @default.
• W18307508 cites W2028038006 @default.
• W18307508 cites W2028253068 @default.
• W18307508 cites W2029086142 @default.
• W18307508 cites W2037191183 @default.
• W18307508 cites W2038809664 @default.
• W18307508 cites W2039034479 @default.
• W18307508 cites W2041926656 @default.
• W18307508 cites W2043103956 @default.
• W18307508 cites W2047255238 @default.
• W18307508 cites W2047655212 @default.
• W18307508 cites W2048198188 @default.
• W18307508 cites W2049225751 @default.
• W18307508 cites W2051120695 @default.
• W18307508 cites W2051183427 @default.
• W18307508 cites W2053253135 @default.
• W18307508 cites W2054673682 @default.
• W18307508 cites W2055827129 @default.
• W18307508 cites W2058680827 @default.
• W18307508 cites W2064074669 @default.
• W18307508 cites W2066714278 @default.
• W18307508 cites W2069232844 @default.
• W18307508 cites W2071658004 @default.
• W18307508 cites W2071751989 @default.
• W18307508 cites W2071900493 @default.
• W18307508 cites W2072780644 @default.
• W18307508 cites W2073738021 @default.
• W18307508 cites W2074739656 @default.
• W18307508 cites W2079212189 @default.
• W18307508 cites W2080875376 @default.
• W18307508 cites W2082280507 @default.
• W18307508 cites W2082431893 @default.
• W18307508 cites W2082812256 @default.
• W18307508 cites W2082817039 @default.

• next